Bionano Genomics (BNGO) Current Leases (2021 - 2025)
Bionano Genomics (BNGO) has disclosed Current Leases for 5 consecutive years, with $697000.0 as the latest value for Q4 2025.
- Quarterly Current Leases fell 76.7% to $697000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $697000.0 through Dec 2025, down 76.7% year-over-year, with the annual reading at $697000.0 for FY2025, 76.7% down from the prior year.
- Current Leases hit $697000.0 in Q4 2025 for Bionano Genomics, down from $1.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $3.0 million in Q4 2024 to a low of $263000.0 in Q3 2024.
- Historically, Current Leases has averaged $1.1 million across 5 years, with a median of $1.0 million in 2025.
- Biggest five-year swings in Current Leases: tumbled 84.53% in 2023 and later surged 999.63% in 2024.
- Year by year, Current Leases stood at $299000.0 in 2021, then decreased by 4.68% to $285000.0 in 2022, then decreased by 4.56% to $272000.0 in 2023, then soared by 999.63% to $3.0 million in 2024, then crashed by 76.7% to $697000.0 in 2025.
- Business Quant data shows Current Leases for BNGO at $697000.0 in Q4 2025, $1.0 million in Q3 2025, and $1.3 million in Q2 2025.